Phase I study of the humanised anti-EGFR monoclonal antibody matuzumab (EMD 72000) combined with gemcitabine in advanced pancreatic cancer

por Graeven, U, Kremer, B, Südhoff, Th, Killing, B, Rojo, F, Weber, D, Tillner, J, ünal, C, Schmiegel, W
Publicado 2006